Antibodies against cancer produced using masked cancer cells as immunogen

Details for Australian Patent Application No. 2005271893 (hide)

Owner Alexion Pharmaceuticals, Inc.

Inventors Maruyama, Toshiaki; Xin, Hong; Dakappagari, Naveen; Bowdish, Katherine S.

Agent Shelston IP

Pub. Number AU-A-2005271893

PCT Pub. Number WO2006/017174

Priority 60/586,812 10.07.04 US

Filing date 8 July 2005

Wipo publication date 16 February 2006

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2006/017174 Priority application(s): WO2006/017174

4 December 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005271897-Compositions and methods of use for treatment of mammalian diseases

2005271892-Methods for discovering antibodies specific to cancer cells and antibodies discovered thereby